Implementation of quality indicators from the S3 guideline palliative medicine for patients with non-curable cancer in clinical practice at palliative care units

Implementation of quality indicators from the S3 guideline palliative medicine for patients with non-curable cancer in clinical practice at palliative care units - Quincie

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00029965

Enrollment

893

Registered

2023-01-20

Start date

2023-08-07

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C00-C97

Interventions

Group 1: No intervention and control group because of the non-interventional design of this study. Different study population for each work package: AP1a: Palliative care units in the commuting area

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: AP1a: Responsible staff of the palliative care units in the commuting area of the CCC-N. AP1b-1c: Data documented in clinical treatment routine of patients with cancer (ICD10 chapter malignant neoplasms: C00-C97) and a minimum age of 18 years with an inpatient stay of at least three nights at one of the participating palliative care units in the last 12 months prior to data collection. AP2b-2c: Experts for inpatient palliative care, care providers in the cooperating clinics, for example clinical specialists (medical and nursing managers at palliative care units), stakeholders at the meso and macro level of the health care system (e.g. staff from the hospice and palliative care association, from the medical guideline programm oncology and from the coordination centre for palliative medicine of the CCC-N).

Exclusion criteria

Exclusion criteria: AP1a, 2b-2c: No adequate knowledge of the German language. AP1b-1c: Death, transfer or discharge before the end of the third night or/and lack of consent for the scientific use of patient data.

Design outcomes

Primary

Measure	Time frame
1) A comprehensive picture of the practical implementation of the quality indicators of the S3 guideline palliative medicine in clinical practice on palliative care units in the commuting area of the CCC-N 2) Recommendations for adapting and optimising the implementation of guideline contents on palliative care units	—

Secondary

Measure	Time frame
Arm 1 and 2: In particular, it will be investigated which quality indicators are implemented in clinical practice and how they are documented as well as which facilitating and detaining factors have an influence on the implementation of the S3 guideline palliative medicine.	—

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 6, 2026